BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 31599488)

  • 1. FDG PET-CT in pediatric Langerhans cell histiocytosis.
    Jessop S; Crudgington D; London K; Kellie S; Howman-Giles R
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28034. PubMed ID: 31599488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of
    Albano D; Bosio G; Giubbini R; Bertagna F
    Jpn J Radiol; 2017 Oct; 35(10):574-583. PubMed ID: 28748503
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Obert J; Vercellino L; Van Der Gucht A; de Margerie-Mellon C; Bugnet E; Chevret S; Lorillon G; Tazi A
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):598-610. PubMed ID: 27645693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of
    Liao F; Luo Z; Huang Z; Xu R; Qi W; Shao M; Lei P; Fan B
    Contrast Media Mol Imaging; 2022; 2022():8385332. PubMed ID: 36051931
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Garcia JR; Riera E; Bassa P; Mourelo S; Soler M
    Rev Esp Med Nucl Imagen Mol; 2017; 36(5):325-328. PubMed ID: 28262495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepancies between F-18-FDG PET/CT findings and conventional imaging in Langerhans cell histiocytosis.
    Ferrell J; Sharp S; Kumar A; Jordan M; Picarsic J; Nelson A
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28891. PubMed ID: 33442960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The usefulness of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with Langerhans cell histiocytosis.
    Lee HJ; Ahn BC; Lee SW; Lee J
    Ann Nucl Med; 2012 Nov; 26(9):730-7. PubMed ID: 22797842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The added value of skeletal surveys in the initial evaluation of children diagnosed with Langerhans cell histiocytosis in the era of staging
    Rameh V; Voss S; Bedoya MA; Beaulieu D; Zhang D; Degar BA; Tsai A
    Pediatr Blood Cancer; 2023 Jan; 70(1):e30057. PubMed ID: 36266951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of 18F-FDG PET/CT in Langerhans cell histiocytosis.
    An R; Ma X; Wang Y
    Ann Nucl Med; 2024 Mar; 38(3):238-245. PubMed ID: 38217750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET-CT in pediatric Langerhans cell histiocytosis.
    Kaste SC; Rodriguez-Galindo C; McCarville ME; Shulkin BL
    Pediatr Radiol; 2007 Jul; 37(7):615-22. PubMed ID: 17564738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis.
    Phillips M; Allen C; Gerson P; McClain K
    Pediatr Blood Cancer; 2009 Jan; 52(1):97-101. PubMed ID: 18951435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary study on the evaluation of Langerhans cell histiocytosis using F-18-fluoro-deoxy-glucose PET/CT.
    Zhou W; Wu H; Han Y; Wang S; Dong Y; Wang Q
    Chin Med J (Engl); 2014; 127(13):2458-62. PubMed ID: 24985583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of whole-body DW-MRI with 2-[
    Baratto L; Nyalakonda R; Theruvath AJ; Sarrami AH; Hawk KE; Rashidi A; Shen S; States L; Aboian M; Jeng M; Daldrup-Link HE
    Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1689-1698. PubMed ID: 36717409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restaging [
    Mahajan S; Barker CA; Mauguen A; Singh B; Pandit-Taskar N
    J Am Acad Dermatol; 2020 Apr; 82(4):878-886. PubMed ID: 31562942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorrine-18-fluorodeoxyglucose positron emission tomography/computed tomography of adult liver Langerhans cell histiocytosis.
    Ji H; Wu J; Yang G; Sun C; Zhu H; Zhang L
    Hell J Nucl Med; 2017; 20(1):97-99. PubMed ID: 28315918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical course of the bony lesion of single-system single-site Langerhans cell histiocytosis - Is appropriate follow-up sufficient treatment?
    Sasaki H; Nagano S; Shimada H; Nakamura S; Setoguchi T; Komiya S
    J Orthop Sci; 2018 Jan; 23(1):168-173. PubMed ID: 28927957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective CT for PET/CT: dose reduction in Langerhans cell histiocytosis.
    Gelfand MJ; Sharp SE; Palumbo JS
    Pediatr Radiol; 2015 Jan; 45(1):81-5. PubMed ID: 25149158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete response of adult-onset CNS Langerhans cell histiocytosis documented on 18F-FDG PET/CT.
    Kruljac I; Balenović A; Gaćina P; Imashuku S; Vrkljan M
    Clin Nucl Med; 2015 Dec; 40(12):981-2. PubMed ID: 26402130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.